Impairment of vesicular ATP release affects glucose metabolism and increases insulin sensitivity

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Sakamoto, Shohei ^a   Miyaji, Takaaki ^b   Hiasa, Miki ^c   Ichikawa, Reiko ^d   Uematsu, Akira ^d   Iwatsuki, Ken ^d   Shibata, Atsushi ^a   Uneyama, Hisayuki ^d   Takayanagi, Ryoichi ^a   Yamamoto, Akitsugu ^e   Omote, Hiroshi ^c   Nomura, Masatoshi ^a   Moriyama, Yoshinori ^b,c  

^a KYUSHU UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d AJINOMOTO CO INC   (Japan)

^e NAGAHAMA INSTITUTE OF BIO SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CATECHOLAMINE; GLUCOSE; GLUCOSE BLOOD LEVEL; INSULIN; NUCLEOTIDE; NUCLEOTIDE TRANSPORTER; SLC17A9 PROTEIN, MOUSE;

ANIMAL; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; KNOCKOUT MOUSE; METABOLISM; MOUSE; SECRETION (PROCESS); SECRETORY VESICLE; TRANSPORT AT THE CELLULAR LEVEL;

ADENOSINE TRIPHOSPHATE; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; CATECHOLAMINES; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; MICE; MICE, KNOCKOUT; NUCLEOTIDE TRANSPORT PROTEINS; NUCLEOTIDES; SECRETORY VESICLES;

EID: 84936146754     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06689     Document Type: Article

References (49)

1. Winkler, H. & Carmichael, S. W. in The Secretory granule, Poisner, A. M. & Trifaro, J. M. Eds. (Elsevier Biomedical, Amsterdam, 1982), pp 3-79.
2. Johnson, R. G., Carty, S. E. & Scarpa, A. Catecholamine transport and energy-linked function of chromaffin granules isolated from a human pheochromocytoma. Biochim. Biophys. Acta 716, 366-176 (1982).
3. Johnson, R. G. Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport. Physiol. Rev. 68, 232-307 (1988).
4. Laslop, A. & Mahata, S. K. Neuropeptide and chromogranins: session overview. Ann. NY Acad. Sci. 971, 294-299 (2002).
5. Schuldiner, S., Shirvan, A. & Linia, M. Vesicular neurotransmitter transporters: From bacteria to humans. Physiol. Rev. 75, 369-392 (1955).
6. Burnstock, G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87, 659-797 (2007).
7. 21 channel currents in cultured bovine adrenal chromaffin cells. Neuron 16, 1027-1036 (1996).
8. Harkins, A. B. & Fox, A. P. Activation of purinergic receptors by ATP inhibits secretion in bovine adrenal chromaffin cells. Brain Res. 885, 231-239 (2000).
9. 12 receptor in nucleotide inhibition of exocytosis from bovine chromaffin cells. Mol. Pharmacol. 66, 601-611 (2004).
10. Reichsman, F., Santos, S. & Westhead, E. W. Two distinct ATP receptors activate calcium entry and internal calcium release in bovine chromaffin cells. J. Neurochem. 65, 2080-2086 (1995).
11. 21-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells. BMC Neurosci. 8, 39 (2007).
12. 2 receptor localization on adrenaline- and noradrenaline containing chromaffin cells in the rat adrenal gland during development and ageing. Int. J. Dev. Neurosci. 23, 567-573 (2005).
13. Afework, M. & Burnstock, G. Distribution of P2X receptors in the rat adrenal gland. Cell Tissue Res. 298, 449-456 (1999).
14. Petit, P., Lajoix, A. D. & Gross, R. P2 purinergic signalling in the pancreatic beta-cell: control of insulin secretion and pharmacology. Eur. J. Pharm. Sci. 37, 67-75 (2009).
15. Novak, I. Purinergic receptors in the endocrine and exocrine pancreas. Purinergic Signaling 4, 237-253 (2008).
16. 3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell. Proc. Natl. Acad. Sci. USA 107, 6465-6470 (2010).
17. Silva, A. M. et al. Electrophysiological and immunocytochemical evidence for P2X purinergic receptors in pancreatic beta cells. Pancreas 36, 279-283 (2008).
18. 1 receptor is involved in the maintenance of glucose homeostasis and in insulin secretion in mice. Purinergic Signaling 1, 145-151 (2005).
19. Gachet, C. P2 receptors, platelet function and pharmacological implications. Thromb. Haemost. 99, 466-472 (2008).
20. 1-deficient mice. Nat. Med. 5, 1199-1202 (1999).
21. 12 receptor in platelet activation. Platelets 22, 54-58 (2011).
22. Sawada, K. et al. Identification of a vesicular nucleotide transporter. Proc. Natl. Acad. Sci. USA 105, 5683-5686 (2008).
23. Larsson, M. et al. Functional and anatomical identification of a vesicular transporter mediating neuronal ATP release. Cereb. Cortex 22, 1203-1214 (2012).
24. Suckale, J. & Solimena, M. The insulin secretory granule as a signaling hub. Trend Endocrinol. Metab. 21, 599-609 (2010).
25. Eliasson, L. et al. Novel aspects of the molecular mechanisms controlling insulin secretion. J. Physiol. 586, 3313-3324 (2008).
26. Harada, Y. & Hiasa, M. Immunological identification of vesicular nucleotide transporter in intestinal L cells. Biol. Pharm. Bull. 37, 1090-1095 (2014).
27. Samuel, V.T. & Shulman, G.I. Mechanism for insulin resistance: common threads and missing links. Cell 148, 852-871 (2012).
28. Burnstock, G., Krügel, U., Abbracchio, M. P. & Illes, P. Purinergic signalling: from normal behaviour to pathological brain function. Prog. Neurobiol. 95, 229-274 (2011).
29. Kopell, W. N. & Westhead, E. W. Osmotic pressures of solutions of ATP and catecholamines relating to storage in chromaffin granules. J. Biol. Chem. 257, 5707-5710 (1982).
30. Phillips, J. H. & Morton, A. G. Adenosine triphosphate in the bovine chromaffin granule. J. Physiol. 74, 503-508 (1978).
31. Geisler, J. C. et al. Vesicular nucleotide transporter-mediated ATP release regulates insulin secretion. Endocrinology 154, 675-684 (2013).
32. Johansson, S. M. et al. A1 receptor deficiency causes increased insulin and glucagon secretion in mice. Biochem. Pharmacol. 74, 1628-1635 (2007).
33. Hillaire-Buys, D. et al. Stimulation of insulin secretion and improvement of glucose tolerance in rat and dog by the P2Y-purinoreceptor agonist, adenosine-59-O-(2-thiodiphosphate). Br. J. Pharmacol. 109, 183-187 (1993).
34. Amisten, S. et al. ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice. Diabetologia 53, 1927-1934 (2010).
35. Chatterjee, C. & Sparks, D. L. Extracellular nucleotides inhibit insulin receptor signaling, stimulate autophagy and control lipoprotein. PLoS ONE 7, e36916 (2012).
36. Enjyoji, K. et al. Deletion of Cd39/Entpd1 results in hepatic insulin resistance. Diabetes 57, 2311-2320 (2008).
37. Osorio-Fuentealba, C. et al. Electrical stimuli release ATP to increase glut4 translocation and glucose uptake via PI3Kc-Akt-AS160 in skeletal muscle cells. Diabetes 62, 1519-1526 (2013).
38. Bankston, L. A. & Guidotti, G. Characterization of ATP transport into chromaffin granule ghosts: Synergy of ATP and serotonin accumulation in chromaffin granule ghosts. J. Biol. Chem. 271, 17132-17138 (1996).
39. Gilabert, J. A., Montalvo, G. B. & Artalejo, A. R. Rat chromaffin cells primary cultures: Standardization and quality assessment for single-cell assays. Nat. Protoc. 2006; 10.1038/nprot.2006.294.
40. Lacy, P. E. & Kostianovsky, M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16, 35-39 (1967).
41. Hayashi, M. et al. Secretory granule-mediated cosecretion of L-glutamate and glucagon triggers glutamatergic signal transmission in islets of Langerhans. J. Biol. Chem. 278, 1966-1974 (2003).
42. Miyaji, T. et al. Identification of a vesicular aspartate transporter. Proc. Natl. Acad. Sci. USA 105, 11720-11724 (2008).
43. -/γ-aminobutyrate co-transporter. J. Biol. Chem. 284, 35073-35078 (2009).
44. Hayashi, M. et al. Synaptic vesicle protein SV2B, but not SV2A, is predominantly expressed and associated with microvesicles in rat pinealocytes. J. Neurochem. 71, 356-365 (1988).
45. Moriyama, Y., Yamamoto, A., Tagaya, M., Tashiro, Y. & Michibata, H. Localization of N-ethylmaleimide-sensitive fusion protein in pinealocytes. Neuroreport 6, 1757-1760 (1995).
46. Yamamoto, A. & Masaki, R. Pre-embedding nanogold silver and gold intensification. Methods Mol. Biol. 657, 225-235 (2010).
47. Fan, W. et al. Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54, 1000-1008 (2005).
48. Ansorge, M. S., Zhou, M., Lira, A., Hen, J. & Gingrich, J. A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306, 879-881 (2004).
49. Ueki, K. et al. Increased insulin sensitivity in mice lacking p85β subunit of phosphoinositide 3-kinase. Proc. Natl. Acad. Sci. USA 99, 419-424 (2002).